- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study Says Better Online Transparency Tools, Apps Could Ease Fear of Lower-Cost Healthcare
You get what you pay for: That old saw applies to most corners of American consumerism, but not to healthcare. Convincing people of that is tough.
You get what you pay for: That old saw applies to most corners of American consumerism, but not to healthcare. Convincing people of that is tough.
The research shows that most Americans believe more-expensive healthcare is usually better—an assumption that has become one major driver of unnecessary costs plaguing the U.S. healthcare system. And researchers say it will take more than just high out-of-pocket costs borne by consumers to change their views.
“People are afraid of the low-cost option because they are afraid of substandard care,” said Judith Hibbard, a senior researcher at the University of Oregon and renowned scholar on consumerism in healthcare, whose comments Tuesday came during a presentation in Chicago at the Operations and Technology Forum held by America's Health Insurance Plans.
The trick to alleviating the fear of lower-cost healthcare is to show Americans the cost of their care alongside the relevant quality rankings for potential providers they could visit. And many of the existing healthcare transparency tools could stand to improve in this regard, according to a study out Wednesday from Catalyst for Payment Reform, a not-for-profit organization that works on behalf of large employers and other healthcare purchasers.
Read the full story here: http://bit.ly/1aINrOv
Source: Modern Healthcare
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
